학술논문
Phase 1 trial supports safety and mechanism of action of peptide immunotherapy for peanut allergy
Document Type
Article
Author
Source
In: Allergy: European Journal of Allergy and Clinical Immunology . (Allergy: European Journal of Allergy and Clinical Immunology, February 2024, 79(2):485-498)
Subject
Language
English
ISSN
13989995
01054538
01054538